IFA

(redirected from Immunofluorescent assay)
Also found in: Medical, Encyclopedia.

IFA

abbreviation for
(Banking & Finance) independent financial adviser
Mentioned in ?
References in periodicals archive ?
Serum samples were submitted to indirect immunofluorescent assay (IFA) with antigens of Leishmania chagasi, adopting 40 as the cutoff titer for positivity.
In addition, serum samples were tested by indirect immunofluorescent assay for specific IgG and IgM against Francisella tularensis and Rickettsia spp.
2638 Enzyme immunoassay (EIA) followed by immunofluorescent assay (IFA) ** 2639 IFA followed by EIA ** 2640 EIA testing only ** 2641 IFA testing only ** 0010 Other, specify: __ ** 1871 ANCA testing not performed If your laboratory does not perform ANCA testing, please stop here.
Indirect Immunofluorescent assay Kit for the screening and semi-quantitative determination of anti-nuclear antibodies (ANA) in mouse serum (not less than 50 samples)
The metabolite cis-hydroxy-amitriptyline was also detected by the polarized immunofluorescent assay used in this study.
Methods: The specimens were processed by cell culture and immunofluorescent assay (IFA) and real-time reverse transcriptase-PCR (rRT-PCR) for detection of respiratory viruses.
Physicians have three options for testing for the other arboviruses: a commercially available immunofluorescent assay kit marketed by Focus Diagnostics; most state health departments will perform testing; and the CDC accepts specimens for testing at its Fort Collins laboratory
To analyse the capability of produced antibody to recognize iligenitalitim in infected cells, indirect immunofluorescent assay was performed.
However, suckling mice inoculation for virus isolation, a laborious and time consuming technique which requires many passages has been replaced by recent techniques such as immunofluorescent assay using serotype specific monoclonal antibodies.
A sample of the patient's prostate tissue is stained with a multiplex immunofluorescent assay to highlight androgen receptor antibodies and other antibodies, which are then analyzed with special software to predict the likelihood of clinical failure within 5 years.